G2GBIO Inc. Stock: price and insider trades · South Korea

Every trade that managers of G2GBIO Inc. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. Between 5 November 2025 and 5 November 2026, 13 insiders published 30 filings.

Both sides are active: 28 purchases worth €132k and 1 sale, from 12 insiders and 1 insider respectively. The totals exclude 24 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The largest single trade was a purchase of €53k by 이희용, published on 27 March 2026, equal to 0.013% of the market capitalisation. On the buying side, the filings list 9 board members, 2 senior executives and 2 chief executives among the declarants.

Within a 30-day window, 4 purchases overlapped with buying by a second insider. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The most recent open-market purchase was published on 5 August 2026, 96 days ago. Typically, a trade is published a median of 2 days after it takes place. Until a filing is published, the market cannot know about the trade.

With 30 filings in twelve months, the company is more active than the median of 7 filings across the 2,656 companies we follow on the same exchange. The full history, which starts in 2025, counts 29 purchases against 1 sale.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Source: insider filings from DART (FSS). Past trades are no guide to future returns.